stockrowEnvista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
- Revenue
- +3.22%
- EPS
- +1,855.6%
- Free cash flow
- −6.48%
- Total debt
- −1.13%
Quarter to September 2026, against a year earlier
Follow NVST
Alert me
Envista Holdings Corporation (NVST) Net income
Envista Holdings Corporation's net income for fiscal 2025 was $47.0M, compared with −$1.1B in fiscal 2024. Over the twelve months to 30 September 2026 it was $633.6M. Over the past ten years it has ranged from −$1.1B (fiscal 2024) to $340.5M (fiscal 2021); the current reading is higher than 40% of that period. Envista Holdings Corporation ranks 7th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $47.0M | — |
| FY2024 | −$1.1B | — |
| FY2023 | −$100.2M | — |
| FY2022 | $243.1M | (28.60%) |
| FY2021 | $340.5M | 922.52% |
| FY2020 | $33.3M | (84.70%) |
| FY2019 | $217.6M | (5.68%) |
| FY2018 | $230.7M | (23.38%) |
| FY2017 | $301.1M | 10.70% |
| FY2016 | $272.0M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $508.3M | 846.55% |
| Jun 2026 | $53.7M | 38.76% |
| Mar 2026 | $38.7M | 17.63% |
| Dec 2025 | $32.9M | — |
| 30 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| NVST Envista Holdings Corporation | $633.6M |
| STVN Stevanato Group S.p.A. compare | $227.4M |
| MMSI Merit Medical Systems, Inc. compare | $160.1M |
| ICUI ICU Medical, Inc. compare | $60.3M |
| ATRC AtriCure, Inc. compare | $14.9M |
| WRBY Warby Parker Inc. compare | $7.5M |
| PLSE Pulse Biosciences, Inc compare | −$83.8M |
| MMED MiniMed Group, Inc. compare | −$320.0M |
| TFX Teleflex Incorporated compare | −$1.0B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on NVST
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement